PROTIER Biotech Inc.
PrivateLast Round
Early Funding
Mar 31, 2026
Total Funding Raised
$2.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PROTIER Biotech Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was an Early Funding round in March 2026.
PROTIER Biotech Inc. is a biotechnology company that develops targeted protein degradation therapeutics and molecular glue platforms for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PROTIER Biotech Inc. Comparables
Compare PROTIER Biotech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UBITAS Biotech | 86% | |
| Magnet Biomedicine | 86% | |
| Proxygen | 84% |
For institutional investors. Book with your work email.
PROTIER Biotech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 31, 2026 | ||||
| Accelerator | Mar 26, 2026 | ||||
| Seed | Jun 1, 2024 |
For institutional investors. Book with your work email.
PROTIER Biotech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Early Funding |
| Korea Investment Accelerator | Early Funding |
| IBK Venture Investment | Early Funding |
| Mirae Science and Technology Holdings | Early Funding |
| T Investment | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Completed an Accelerator round of funding.
For institutional investors. Book with your work email.
PROTIER Biotech Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PROTIER Biotech Inc.'s valuation, stock price, and market status.
Is PROTIER Biotech Inc. a public or private company?
PROTIER Biotech Inc. is a private company.
What is the current stock price of PROTIER Biotech Inc.?
PROTIER Biotech Inc. is a private company, so its shares have no public market price. Caplight tracks PROTIER Biotech Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PROTIER Biotech Inc. worth (valuation)?
Valuation information for PROTIER Biotech Inc. is not publicly available.
Can I buy PROTIER Biotech Inc. stock?
PROTIER Biotech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PROTIER Biotech Inc.'s last funding round?
PROTIER Biotech Inc.'s most recent funding round was Early Funding on March 31, 2026.
Who are the main investors in PROTIER Biotech Inc.?
Key investors in PROTIER Biotech Inc. include Hana Ventures, Korea Investment Accelerator, IBK Venture Investment, Mirae Science and Technology Holdings, T Investment.
Will PROTIER Biotech Inc. IPO soon?
No public IPO plans have been announced for PROTIER Biotech Inc..
How can I track PROTIER Biotech Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PROTIER Biotech Inc.'s shares on secondary markets.